ALEXZA PHARMACEUTICALS INC's ticker is ALXA and the CUSIP is 015384209. A total of 25 filers reported holding ALEXZA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $0 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LANSDOWNE PARTNERS AUSTRIA GMBH | 1,355,255 | $6,410,000 | 100.00% |
| FORTALEZA ASSET MANAGEMENT INC/ | 142,180 | $673,000 | 0.34% |
| Lombard Odier & Cie (Bahamas) Ltd | 44,000 | $208,000 | 0.08% |
| HOWARD HUGHES MEDICAL INSTITUTE | 98,914 | $468,000 | 0.07% |
| KENNEDY CAPITAL MANAGEMENT LLC | 476,645 | $2,255,000 | 0.04% |
| BBT Capital Management, LLC | 118,033 | $558,000 | 0.02% |
| ROCKY MOUNTAIN ADVISERS, LLC | 350 | $2,000 | 0.02% |
| Jefferies Group LLC | 520,400 | $2,461,000 | 0.02% |
| Granite Point Capital Management, L.P. | 16,574 | $78,000 | 0.01% |
| Compagnie Lombard Odier SCmA | 55,000 | $260,000 | 0.01% |